CN1524567A - 血府逐瘀软胶囊及其制备方法 - Google Patents
血府逐瘀软胶囊及其制备方法 Download PDFInfo
- Publication number
- CN1524567A CN1524567A CNA031568963A CN03156896A CN1524567A CN 1524567 A CN1524567 A CN 1524567A CN A031568963 A CNA031568963 A CN A031568963A CN 03156896 A CN03156896 A CN 03156896A CN 1524567 A CN1524567 A CN 1524567A
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- radix
- adjuvant
- root
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000010056 xuefu Substances 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000003814 drug Substances 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 15
- 238000001914 filtration Methods 0.000 claims abstract description 13
- 230000006837 decompression Effects 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 239000006071 cream Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 23
- 239000002671 adjuvant Substances 0.000 claims description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 238000010992 reflux Methods 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 claims description 6
- 229960003511 macrogol Drugs 0.000 claims description 6
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 5
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 5
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 125000004494 ethyl ester group Chemical group 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 5
- 239000008273 gelatin Substances 0.000 claims description 5
- 235000019322 gelatine Nutrition 0.000 claims description 5
- 235000011852 gelatine desserts Nutrition 0.000 claims description 5
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 5
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 5
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 5
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 5
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 5
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 238000004064 recycling Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- AZHSSKPUVBVXLK-UHFFFAOYSA-N ethane-1,1-diol Chemical compound CC(O)O AZHSSKPUVBVXLK-UHFFFAOYSA-N 0.000 claims description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims 2
- 239000008280 blood Substances 0.000 abstract description 8
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000004519 grease Substances 0.000 abstract 5
- 238000009835 boiling Methods 0.000 abstract 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241000244355 Ligusticum Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 239000002893 slag Substances 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 206010002383 Angina Pectoris Diseases 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 208000019622 heart disease Diseases 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 208000037920 primary disease Diseases 0.000 description 5
- 229910010413 TiO 2 Inorganic materials 0.000 description 4
- 208000031225 myocardial ischemia Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- 101710145505 Fiber protein Proteins 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 2
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000007902 hard capsule Substances 0.000 description 2
- 238000003032 molecular docking Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010052895 Coronary artery insufficiency Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031568963A CN1296075C (zh) | 2003-09-12 | 2003-09-12 | 血府逐瘀软胶囊的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB031568963A CN1296075C (zh) | 2003-09-12 | 2003-09-12 | 血府逐瘀软胶囊的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1524567A true CN1524567A (zh) | 2004-09-01 |
CN1296075C CN1296075C (zh) | 2007-01-24 |
Family
ID=34287129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB031568963A Expired - Lifetime CN1296075C (zh) | 2003-09-12 | 2003-09-12 | 血府逐瘀软胶囊的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1296075C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1331465C (zh) * | 2005-09-05 | 2007-08-15 | 天津宏仁堂药业有限公司 | 一种治疗冠心病心绞痛高脂血症的血府逐瘀滴丸及其制备方法 |
CN1981836B (zh) * | 2005-09-05 | 2010-05-19 | 天津宏仁堂药业有限公司 | 一种治疗冠心病心绞痛高脂血症的血府逐瘀滴丸及其制备方法 |
CN106074842A (zh) * | 2016-08-22 | 2016-11-09 | 曹蕊 | 一种用于心脏病的中药提取物的制备方法 |
CN109528938A (zh) * | 2018-11-28 | 2019-03-29 | 李建国 | 一种治疗慢性肾脏的中药及其口服制剂 |
NL2032301B1 (en) * | 2022-03-15 | 2022-12-30 | Zhu Fengtang | Preparation method of blood-activating stasis-removing pills |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552520B (zh) * | 2011-12-31 | 2014-02-12 | 余中华 | 一种活血止痛胶囊及制备工艺和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1060344C (zh) * | 1992-11-28 | 2001-01-10 | 中国人民解放军第371医院 | 治疗缺血性脑血管、心血管的药物制剂 |
CN1491706A (zh) * | 2003-08-02 | 2004-04-28 | 浙江天一堂集团有限公司 | 血府逐瘀软胶囊及其制备方法 |
-
2003
- 2003-09-12 CN CNB031568963A patent/CN1296075C/zh not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1331465C (zh) * | 2005-09-05 | 2007-08-15 | 天津宏仁堂药业有限公司 | 一种治疗冠心病心绞痛高脂血症的血府逐瘀滴丸及其制备方法 |
CN1981836B (zh) * | 2005-09-05 | 2010-05-19 | 天津宏仁堂药业有限公司 | 一种治疗冠心病心绞痛高脂血症的血府逐瘀滴丸及其制备方法 |
CN106074842A (zh) * | 2016-08-22 | 2016-11-09 | 曹蕊 | 一种用于心脏病的中药提取物的制备方法 |
CN109528938A (zh) * | 2018-11-28 | 2019-03-29 | 李建国 | 一种治疗慢性肾脏的中药及其口服制剂 |
NL2032301B1 (en) * | 2022-03-15 | 2022-12-30 | Zhu Fengtang | Preparation method of blood-activating stasis-removing pills |
Also Published As
Publication number | Publication date |
---|---|
CN1296075C (zh) | 2007-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1286513C (zh) | 一种治疗皮肤病的中药组合物及其制备方法 | |
WO2006060951A1 (fr) | Composition pharmaceutique pour le traitement et/ou la prevention de l’hyperlipidemie, procedes de production et utilisation de cette composition | |
CN101596295B (zh) | 一种用于治疗痛风的药物组合物及其制备工艺 | |
US11160842B2 (en) | Drug or health care product preventing or treating liver and kidney damage-related diseases and use thereof | |
CN105535448A (zh) | 一种治疗儿童重症肌无力的中药组合物 | |
CN1296075C (zh) | 血府逐瘀软胶囊的制备方法 | |
CN100339068C (zh) | 一种治疗冠心病心绞痛的滴丸剂及其制备方法 | |
CN100500183C (zh) | 一种治疗妇女经期疾病的中药合剂的制备方法 | |
US20160000849A1 (en) | Composition for remedying or treating rheumatoid arthritis and osteoarthritis | |
CN1039879C (zh) | 脑血通口服液 | |
CN1025774C (zh) | 一种特效型山海丹及其生产方法 | |
CN1166397C (zh) | 一种治疗心脑系统疾病、中风后遗症的药物 | |
CN1121810A (zh) | 治疗骨质疏松症的中药复方制剂及其制法 | |
CN1814153A (zh) | 一种预防和治疗乳腺癌的药物组合物及其制备方法 | |
CN101744906A (zh) | 一种中药组合物在制备治疗面神经麻痹药物中的应用 | |
CN1733141A (zh) | 一种用于治疗黄褐斑、痤疮的新制剂 | |
CN100475248C (zh) | 一种治疗子宫出血的药物及其制备工艺 | |
CN1313139C (zh) | 治疗血管神经性头痛药物的制备方法 | |
KR100552991B1 (ko) | 진교로부터 유효 활성 성분의 추출·정제 방법과 그 추출물을함유한 생약 조성물 | |
CN1456236A (zh) | 妇乐泡腾颗粒的制备方法 | |
CN116211945B (zh) | 一种中药组合物及其制备方法与在制备用于治疗或预防慢性脑供血不足的药物中的应用 | |
CN108310074B (zh) | 一种具有益气补虚、活血通络作用的中药组合物及其制备方法 | |
CN1456237A (zh) | 新妇乐冲剂的制备方法 | |
CN1046284A (zh) | 齿痛宁的新制法 | |
CN1943717A (zh) | 一种治疗低血压症的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CI01 | Publication of corrected invention patent application |
Correction item: Applicant Correct: BEIJING GUORENTANG PHARMACEUTICAL SCIENCE AND TECHNOLOGY DEVELOPMENT Co.,Ltd. False: BEIJING TONG REN TANG MEDICAL SCIENCE AND TECHNOLOGY DEVELOPMENT Co.,Ltd. Number: 35 Volume: 20 |
|
CI02 | Correction of invention patent application |
Correction item: Applicant Correct: BEIJING GUORENTANG PHARMACEUTICAL SCIENCE AND TECHNOLOGY DEVELOPMENT Co.,Ltd. False: BEIJING TONG REN TANG MEDICAL SCIENCE AND TECHNOLOGY DEVELOPMENT Co.,Ltd. Number: 35 Page: The title page Volume: 20 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: BEIJING TONG REN TANG MEDICAL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. TO: BEIJING GUO REN TANG MEDICAL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. |
|
ERR | Gazette correction |
Free format text: CORRECT: APPLICANT; FROM: BEIJING TONG REN TANG MEDICAL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. TO: BEIJING GUO REN TANG MEDICAL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JILIN PROVINCE HUINAN HUIFA PHARMACY STOCK CO., LT Free format text: FORMER OWNER: BEIJING GUO REN TANG MEDICAL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20090710 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090710 Address after: Beijing City, Xuanwu District, 53 Hospital No. 2 Building 2 unit 801 room Patentee after: Jilin Huinan Huifa Pharmaceutical Co.,Ltd. Address before: Room 8, building 32, No. 602, Pure Land Temple, four crossing road, Beijing, Haidian District Patentee before: BEIJING GUORENTANG PHARMACEUTICAL SCIENCE AND TECHNOLOGY DEVELOPMENT Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: JILIN HUINAN SANHE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: JILIN HUINAN HUIFA PHARMACEUTICAL CO., LTD. Effective date: 20130219 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100054 XUANWU, BEIJING TO: 135100 TONGHUA, JILIN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130219 Address after: The pharmaceutical industry park 135100 Huinan County, Jilin Province Economic and Technological Development Zone No. 6 Yongkang Road Patentee after: JILIN PROVINCE HUINAN SANHE PHARMACEUTICAL CO.,LTD. Address before: 100054 Beijing city Xuanwu District, 53 Hospital No. 2 Building 2 unit 801 room Patentee before: Jilin Huinan Huifa Pharmaceutical Co.,Ltd. |
|
CX01 | Expiry of patent term |
Granted publication date: 20070124 |
|
CX01 | Expiry of patent term |